Non-ribosomal peptide synthetases are giant enzymes composed of modules that house repeated sets of functional domains, which select, activate and couple amino acids drawn from a pool of nearly 500 potential building blocks 1 . The structurally and stereochemically diverse peptides generated in this manner underlie the biosynthesis of a large sector of natural products. Many of their derived metabolites are bioactive such as the antibiotics vancomycin, bacitracin, daptomycin and the b-lactam-containing penicillins, cephalosporins and nocardicins. Penicillins and cephalosporins are synthesized from a classically derived non-ribosomal peptide synthetase tripeptide (from d-(L-a-aminoadipyl)-L-cysteinyl-D-valine synthetase) 2 . Here we report an unprecedented non-ribosomal peptide synthetase activity that both assembles a serine-containing peptide and mediates its cyclization to the critical b-lactam ring of the nocardicin family of antibiotics. A histidine-rich condensation domain, which typically performs peptide bond formation during product assembly, also synthesizes the embedded four-membered ring. We propose a mechanism, and describe supporting experiments, that is distinct from the pathways that have evolved to the three other b-lactam antibiotic families: penicillin/cephalosporins, clavams and carbapenems. These findings raise the possibility that b-lactam rings can be regio-and stereospecifically integrated into engineered peptides for application as, for example, targeted protease inactivators 3,4 .
Non-ribosomal peptide synthetases are giant enzymes composed of modules that house repeated sets of functional domains, which select, activate and couple amino acids drawn from a pool of nearly 500 potential building blocks 1 . The structurally and stereochemically diverse peptides generated in this manner underlie the biosynthesis of a large sector of natural products. Many of their derived metabolites are bioactive such as the antibiotics vancomycin, bacitracin, daptomycin and the b-lactam-containing penicillins, cephalosporins and nocardicins. Penicillins and cephalosporins are synthesized from a classically derived non-ribosomal peptide synthetase tripeptide (from d-(L-a-aminoadipyl)-L-cysteinyl-D-valine synthetase) 2 . Here we report an unprecedented non-ribosomal peptide synthetase activity that both assembles a serine-containing peptide and mediates its cyclization to the critical b-lactam ring of the nocardicin family of antibiotics. A histidine-rich condensation domain, which typically performs peptide bond formation during product assembly, also synthesizes the embedded four-membered ring. We propose a mechanism, and describe supporting experiments, that is distinct from the pathways that have evolved to the three other b-lactam antibiotic families: penicillin/cephalosporins, clavams and carbapenems. These findings raise the possibility that b-lactam rings can be regio-and stereospecifically integrated into engineered peptides for application as, for example, targeted protease inactivators 3, 4 .
Despite their widespread use for more than half a century, the b-lactam antibiotics, represented most familiarly by the semi-synthetic penicillins and cephalosporins, remain the most frequently prescribed anti-infectives in human medicine 5, 6 . Four structurally distinct clans occur naturally, and the more recently discovered of these and their synthetic variants are of increasing importance to combat the rising spectre of antibiotic-resistant infectious diseases 7, 8 . Members of this group of antibiotics contain monocyclic and fused bicyclic b-lactams whose high energy, strained-ring skeletons are essential to their antimicrobial activities. Markedly different but chemically efficient biosynthetic pathways have evolved to each of the penicillin and cephalosporin (for example isopenicillin N and cephalosporin C) 9 , clavulanic acid 10 and carbapenem (for example thienamycin) 11 groups (Fig. 1a, b) . Ironically, the fourth and structurally simplest clan of monocyclic b-lactams, exemplified by nocardicin G (Fig. 2b) , has long remained an unsolved problem 12, 13 .
The nocardicin non-ribosomal peptide synthetase (NRPS) encompasses two megaenzymes, NocA and NocB, which together comprise five modules ( Fig. 2a ). Each module contains an adenylation (A) domain that binds ATP, selects its cognate building block and performs substrate acyl adenylation. The activated amino acid is then translocated as its aminoacyl thioester to the 49-phosphopantetheine 'arm' of the downstream post-translationally modified peptidyl carrier protein (PCP). Condensation (C) domains mediate substrate inter-module amide bond formation to yield peptides of length and sequence defined by the NRPS(s). An epimerization (E) domain is embedded in module 3, which converts its associated amino-acid residue from the L-to the D-configuration. Finally, catalytic turnover of the NRPS is achieved through disconnection of the final peptide product by the carboxyterminal (C-terminal) thioesterase (TE) domain.
Although the roles of NocA and NocB in nocardicin A biosynthesis have remained enigmatic, it was established early on that the O-homoseryl terminus of nocardicin A is derived in an unusual transfer reaction from S-adenosyl-L-methionine 14 and that the b-lactam carbons arise from L-serine ( Fig. 2b) 15 . The two modified p-(hydroxyphenyl)glycine (pHPG) units originate as catabolic products of L-tyrosine 16 . Nocardicin G (Fig. 2b) , the simplest of the nocardicins, is a key pathway intermediate to nocardicin A 17 . As a consequence, it was initially thought that modules 1 and 2 of NocA were inactive to account for an apparent tripeptide NRPS precursor to nocardicin G. Subsequent experimentation, however, demonstrated that all five modules of NocA and NocB are essential to antibiotic production 12 , and careful analysis of each dissected A domain gave the predicted product as L-pHPG-L-Arg-D-pHPG-L-Ser-L-pHPG, a pentapeptide 13 . The role of the amino-terminal (N-terminal) L-pHPG-L-Arg in the biosynthesis was unclear as was the means by which the C-terminal pHPG epimerized from the L-to D-configuration present in nocardicin G. Recent experiments with the nocardicin thioesterase domain (NocTE) shed light on these questions and defined the central problem of b-lactam formation. A series of predicted tri-and pentapeptide and potential seryl O-activated peptide thioesters all failed to undergo hydrolysis at rates greater than controls. On the other hand, the corresponding tri-and pentapeptide thioesters now bearing a preformed b-lactam ring from cyclization of the seryl residue were not only rapidly hydrolysed but also completely epimerized to the C-terminal D-stereochemistry ( Fig. 2c) 18 . NRPS epimerase activity by a TE domain was unprecedented, but this specific instance is due to to the anomalously high acidity of a pHPG a-hydrogen relative to other a-amino acids 18 . Competition experiments established that the L,L,D,L,L-pentapeptide b-lactam thioester is the preferred NocTE substrate 18 , a finding fully in accord with the requirement that all five modules of NocA/B are necessary for nocardicin biosynthesis.
Although NocTE catalyses C-terminal epimerization and hydrolytic product release, it was not observed to mediate b-lactam synthesis 18 . Azetidinone formation, therefore, must logically occur upstream on the NRPS after introduction of the last pHPG unit in module 5 from which the b-lactam ring nitrogen arises. In principle, formation of the embedded b-lactam ring could take place either in cis in this module or occur in trans. The latter alternative invokes the action of auxiliary enzyme(s), which are increasingly precedented in NRPS biochemistry 19 . Among the mechanisms that can be visualized are in trans activation of the seryl hydroxyl group by, for example, phosphorylation or acylation, and intramolecular nucleophilic substitution (S N i) by the adjacent amide to form the critical C4-N bond, a process well supported by chemical precedent 20 and consistent with the observation of stereochemical inversion at the seryl b-carbon 16 . Bioinformatic analysis and biochemical experiments, however, did not point to candidate auxiliary enzyme(s) encoded by the nocardicin biosynthetic gene cluster 21 . As a consequence, experiments were first undertaken to probe the in cis strategy with unexpected results.
The termination module of NocB, module 5, is composed of four domains: C 5 , A 5 , PCP 5 and TE. This 144 kilodalton protein was heterologously expressed in Escherichia coli with a His 6 tag and purified by affinity chromatography. Complete conversion to its corresponding holo form was ensured by Sfp-mediated 49-phosphopantetheinyl transfer from coenzyme A (CoASH) 22, 23 . The final chemical transformations catalysed by the termination module were successfully reconstituted in vitro through incubation of the predicted tetrapeptide-modified PCP domain from module 4 (PCP 4 ) with holo-module 5. Bearing in mind that all five modules of NocA/B are required for production of nocardicin A in Nocardia uniformis, and that the b-lactam-containing pentapeptide is preferentially processed by NocTE over the corresponding tripeptide 18 , L-pHPG-L-Arg-D-pHPG-L-Ser-CoA (1, Fig. 3a ) was prepared (Supplementary Information) and linked to apo-PCP 4 in an Sfp-mediated transfer to create L-pHPG-L-Arg-D-pHPG-L-Ser-S-PCP 4 (2, Fig. 3b and Extended Data Fig. 1 ). It was anticipated that module 5 would activate L-pHPG in the presence of ATP and present this amino acid on PCP 5 for reaction with the tetrapeptide delivered to module 5 by PCP 4 . Indeed, when holo-module 5, 10 equivalents of tetrapeptidyl-S-PCP 4 (2), L-pHPG and ATP were combined, smooth conversion to the pentapeptide b-lactam (pro-nocardicin G) was observed ( Fig. 3c and Extended Data Fig. 2 ). Monitoring product formation by high-performance liquid chromatography (HPLC) in a time-course experiment and simultaneous consumption of tetrapeptidyl-S-PCP 4 (2) by electrospray ionization mass spectrometry (ESI-MS) revealed a 1:1 correlation in accord with full catalytic turnover ( Fig. 3d ). Control experiments lacking L-pHPG or L-pHPG and ATP showed no product formation.
In a negative control experiment, the in vitro reconstitution experiment was repeated with a point mutant of C 5 where the second histidine residue of the conserved active site HHxxxDG sequence, known to be essential for amide bond formation 24 , was replaced by alanine (H792A). No new products were detected ( Fig. 3c ). To further define acceptable substrates for C 5 , the L-pHPG-L-Arg-D-pHPG-L-Ser-S-pantetheine (3, Fig. 3a ) substrate mimic was prepared (Supplementary Information) but did not yield pro-nocardicin G when incubated with holo-module 5, ATP and L-pHPG (Extended Data Fig. 3a, b ), a result that emphasizes the critical importance PCP 4 NC 5 domainNdomain interaction plays to b-lactam formation. Next the dipeptide D-pHPG-L-Ser-CoA (4, Fig. 3a ) 
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was prepared (Supplementary Information) and loaded onto apo-PCP 4 as before to afford D-pHPG-L-Ser-S-PCP 4 (5, Extended Data Fig. 4 ). When this construct was generated in the presence of holo-module 5, L-pHPG and ATP, nocardicin G was not detected (Extended Data Fig. 3c, d) . These data suggest that the L-pHPG-L-Arg 'leader' present in the tetrapeptidyl-S-PCP 4 2 plays a vital role in the binding and/or recognition of the upstream tetrapeptidyl intermediate in C 5 , enabling peptide extension and b-lactam formation to occur. Examination of the primary sequence of C 5 showed no unusual insertions or deletions except that, in addition to the conserved HHXXXDG catalytic motif emblematic of condensation domains, a third His residue (H790) lies directly upstream of the His dyad (Extended Data Fig. 5 ). Sequence analysis also revealed features of a D C L domain despite receiving an L-seryl tetrapeptide from PCP 4 (Extended Data Table 1 ). We propose a mechanism in which His 790 catalyses b-elimination of hydroxide (water) from the seryl residue of the PCP 4 -bound tetrapeptidyl-thioester and PCP 5 -tethered L-pHPG achieves b-addition with overall inversion of configuration at the seryl(dehydroalanyl) b-carbon dictated by earlier stereochemical experiments (Fig. 4a) 25 . The transient loss of the L-seryl stereocentre during the b-elimination/addition may account for the D C L characteristics of C 5 . The resulting b-aminothioester 6 is then proposed to undergo unconventional amide bond cyclization (allowed 4-exo-trig), thermodynamically driven by amide bond formation from the active PCP 4 thioester. The PCP 5 -bound pentapeptide b-lactam (pro-epinocardicin G) is poised for delivery to NocTE for C-terminal epimerization and hydrolytic product release.
To support this mechanistic hypothesis, we prepared a mutant of module 5 in which the tentative catalytic His was replaced by alanine (M5*H790A). Repeating the experiments with PCP 4 -bound tetrapeptide 2 and mutant M5*H790A, L-pHPG and ATP yielded no product (Extended Data Fig. 6 ). Similarly site-specific mutation of the His residue typically involved in peptide bond formation (M5*H792A) also gave no reaction, as anticipated. In a further test of the proposed mechanism, the reactive dehydroalanyl tetrapeptide intermediate (6, Fig. 4b ) was synthesized (Supplementary Information) and used in an Sfp-catalysed reaction to afford the corresponding L-pHPG-L-Arg-D-pHPGdehydroalanyl-S-PCP 4 substrate (7, Fig. 4c and Extended Data Fig. 7 ). In the course of preparing this sensitive material, it was discovered that the addition of sulphur, phosphorus and nitrogen nucleophiles occurred preferentially 1,4 rather than 1,2 in keeping with the hypothetical reactivity posed in Fig. 4a . When PCP 4 -bound dehydroalanyl tetrapeptide 7 was incubated with wild-type holo-module 5, L-pHPG and ATP, b-lactam formation was once again observed ( Fig. 4d and Extended Data Figs 8 and 9 ). Further insight into this process was afforded by the M5*H790A mutant, which did not support complete reaction of the dehydroalanyl substrate to the b-lactam product (Fig. 4d) . The proposed catalytic residue H790 must not only act as a base to promote b-elimination but also serve as the acid to consummate amine (L-pHPG-S-PCP 5 ) b-addition. Although interfering with the proper cycling of the protonation state of the enzyme can be partly compensated in the wild-type protein, it cannot in the M5*H790A mutant.
NRPS C domains are pseudodimeric proteins whose N-and C-terminal subdomains are joined to form an extended V-shaped substrate channel that accommodates the donor and acceptor aminoacyl reactants, each delivered by extended pantetheinyl 'arms' from proximal PCP domains 26 . The centrally located HHXXXDG motif promotes peptide bond formation and transfer of the growing peptide chain to the downstream PCP domain. The unprecedented b-lactam formation catalysed by C 5 is distinct from the iron-mediated oxidative cyclization to penicillin (Fig. 1a ) and the ATP-driven b-amino-acid closures that lead ultimately to clavulanic acid and all of the carbapenems (Fig. 1b) 27 , and it does not correlate to the heterocyclization of serine residues to oxazolidine rings 28 . There is no stereoelectronic imperative that b-elimination/addition reactions must occur with overall retention of stereochemistry 29 . It can be readily appreciated that departure of the seryl OH and conjugate addition of the pHPG amine can take place on opposite faces of the 30 where a prior O-phosphorylation or glutamylation intervenes to facilitate this elimination step. Impressive synthetic efficiency is achieved by the NocB termination module where previously unknown NRPS catalytic capabilities are captured in a non-oxidative route to b-lactams. Parsing a universe of more than 25,000 NRPS sequences to those that contain both a C domain bearing a HHHXXXDG motif and an immediately upstream A domain that is confidently predicted to activate Ser (or Thr) yielded only four Ser hits, two of which are known nocardicin producers 13 , and, interestingly, five Thr hits (Extended Data Table 1 ). The products of the last seven, and whether they are b-lactam containing or not, are not known. The exceeding rarity of even potential b-lactam synthesis by an NRPS is emphasized by these findings, but its discovery at once expands the engineering and synthesis goals that can now be contemplated for this versatile class of giant modular enzymes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Holo-module 5 Figure 4 | Proposed b-lactam formation mechanism. a, Proposed mechanism of b-lactam formation in C 5 . Tentative catalytic roles of histidine residues are indicated. b, Substrate used in this study. c, Incubation of dehydroalanyl tetrapeptidyl-S-PCP 4 7 with holo-module 5, ATP and L-pHPG gave pro-nocardicin G. d, Left: HPLC traces of products obtained after incubation of dehydroalanyl tetrapeptidyl-S-PCP 4 7 and indicated holo-module 5, ATP and L-pHPG. Pro-nocardicin G was observed in the wild-type reaction (1M5(WT)) but not in the mutant (1M5*H790A), verified by comparison with synthetic standard (top trace). Right: LC-MS traces of products obtained after incubation of dehydroalanyl tetrapeptidyl-S-PCP 4 7 and indicated holo-module 5 construct, ATP and L-pHPG. Pro-nocardicin G was observed in the wild-type reaction (1M5(WT)) but not in the mutant (1M5*H790A), verified by comparison with synthetic standard (top trace).

METHODS
No statistical methods were used to predetermine sample size.
Synthesis of all compounds used in this study can be found in the associated Supplementary Information. General methods. Analytical HPLC analyses of enzymatic reactions were performed on an Agilent model 1200 HPLC equipped with a multi-wavelength ultravioletvisible detector in conjunction with a reverse-phase Phenomenex Luna 5u phenyl/ hexyl analytical column (250 mm3 4.60 mm internal diameter). Water 1 ACN 1 0.1% TFA: 0-5 min isocratic 93% water 1 7% ACN 1 0.1% TFA, 5-22 min gradient 7-50% ACN 1 0.1% TFA, 22-25 min gradient 50-7% ACN 1 0.1% TFA, 25-35 min isocratic 93% water 1 7% ACN 1 0.1% TFA. Flow rate 5 1.0 ml min 21 .
Ultra-performance liquid chromatography (UPLC)-HRMS samples were analysed on a Waters Acquity H-Class UPLC system equipped with a multi-wavelength ultraviolet-visible diode array detector in conjunction with a Waters Acquity BEH UPLC column packed with an ethylene bridged hybrid C-18 stationary phase (2.1 mm 3 50 mm, 1.7 mm) in tandem with HRMS analysis by a Waters Xevo-G2 Q-ToF ESI mass spectrometer. Mobile phase: 100% water 1 0.1% formic acid 0-1 min, 1-7.5 min 80% ACN 1 0.1% formic acid, 7.5-8.4 min isocratic 80% ACN 1 0.1% formic acid, 8.4-10 min 100% water 1 0.1% formic acid. Flow rate 5 0.3 ml min 21 . Cloning, expression and purification of His 6 -module 5. The module 5 gene containing C-A-PCP 5 -TE of the termination module in NocB was PCR amplified from the pMG0531 cosmid 21 containing nocA and nocB genes using the M5-forward and M5-reverse primers ( Supplementary Table 1 ) and Herculase-HF DNA polymerase (Agilent Technologies). The resulting PCR product was incorporated into a pCRBlunt-TOPO subcloning vector (Invitrogen) and sequence verified (Johns Hopkins University Core Sequencing Facility). The pCRBlunt-M5 construct was digested with NdeI and HindIII (NEB) and ligated with T4 DNA ligase (NEB) into a similarly digested pET28b (Novagen) vector to create the corresponding N-terminal 63-His fusion construct.
Apo-module 5 was expressed using the pET28b-M5 vector in Rosetta 2(DE3)/ pLysS E. coli cells (Novagen) and cultured at 37 uC in 1 l of 23 YT broth supplemented with 50 mg ml 21 kanamycin and 50 mg ml 21 chloramphenicol. Upon reaching an absorbance at 600 nm of 0.7, the temperature of the culture was reduced to 4 uC for 1 h. The temperature of the culture was raised to 18 uC and expression was induced with1 mM isopropyl a-D-thiogalactopyranoside (IPTG) and grown at 18 uC for 18 h.
The cells were harvested by centrifugation (5,000g, 15 min, 4 uC) and stored at 280 uC. Cells were thawed in lysis buffer (50 mM phosphate, 300 mM NaCl, pH 8.0) and disrupted by sonication (60% amplitude, 9 s on/off, 3 min) on ice. Cell debris was removed by centrifugation (25,000g, 30 min, 4 uC) and the clarified cell lysate was incubated with 2 ml of 50% suspension per litre of cell culture of TALON metal affinity resin (Clontech) for 1-2 h at 4 uC in a batch-binding format. The suspension was loaded onto a gravity column and washed with two volumes of lysis buffer. The desired protein was eluted with a stepwise gradient of imidazole (20-300 mM) in lysis buffer. Fractions containing the purified protein, as determined by SDS-PAGE with Coomassie staining, were pooled and dialysed against 3 l of assay buffer twice containing assay buffer (50 mM HEPES, 25 mM NaCl, pH 7.5). Protein concentrations were quantified by Bradford assay. Construction, expression and purification of His 6 -module 5 point mutants.
Site-directed mutagenesis designed to alter His 790 (H790A) and His 792 (H792A) used the splicing by overlap extension method, from the pET28b-M5 vector, with the appropriate DNA primers for the desired mutant (Supplementary Table 2 ). The reverse primers used in these PCR reactions employed a native PstI restriction site in the module 5 nucleotide sequence. The resulting extension-overlap PCR product was incorporated into a pCRBlunt-TOPO subcloning vector and sequence verified. The pCRBlunt-M5* mutant construct was digested with NdeI and PstI. This extension-overlap product was ligated into a similarly digested pET28b-M5 to provide the desired C domain mutant of full-length M5. Expression and purification of mutant constructs was achieved similarly through procedures described for the wild-type protein.
Construction, expression and purification of His 6 -PCP 4 . Gene pcp 4 from nocB was PCR amplified from the pMG0531 cosmid using the PCP 4 -forward and PCP 4reverse primers ( Supplementary Table 1 ) and Herculase-HF DNA polymerase. The resulting PCR product was incorporated into a pCRBlunt-TOPO subcloning vector and sequence verified. The pCRBlunt-PCP 4 construct was digested with NdeI and NotI and ligated with T4 DNA ligase into a similarly digested pET28b vector to create the corresponding N-terminal 63-His fusion construct. Expression and purification of the PCP 4 monodomain was achieved similarly through procedures described for the module 5 constructs. In vitro reconstitution of module 5 activity. Loading of peptidyl-S-CoA onto apo-PCP 4 . The apo-PCP 4 constructs were converted to their holo forms by an Sfpmediated transfer of the desired peptidyl-S-CoA substrate with the apo-PCP 4 construct. Apo-PCP 4 (200 mM) was incubated with 250 mM of desired peptidyl-S-CoA substrate in assay buffer supplemented with 10 mM MgCl 2 . 49-Phosphopantetheine transfer reactions were initiated by the addition of 2 mM of Sfp, and the enzymatic mixture was incubated for 45 min at room temperature. Excess peptidyl-S-CoA reagent was removed through serial dilutions of the reaction mixture. This was achieved by adding three volumes of assay buffer to the reaction mixture and concentrating the mixture back down to the initial volume using a 3k MWCO Amicon Ultra centrifugal filter (Millipore). This dilution procedure was repeated three times.
Generation of holo-module 5 construct. To a separate 1.5 ml tube, 20 mM of apomodule 5 construct (either wild type or mutant) was incubated with 40 mM coenzyme A in assay buffer supplemented with 10 mM MgCl 2 . 49-Phosphopantetheine transfer was initiated by the addition of 2 mM of Sfp and the reaction was left to stand for 45 min at room temperature. Excess CoA reagent was removed through serial dilutions of the enzymatic mixture as before.
Module-5-catalysed b-lactam formation. Holo-module 5 constructs were supplemented with 5 mM ATP and 2 mM L-pHPG and left to stand for 5 min in assay buffer. Condensation reactions were initiated by adding equal volumes of peptidyl-S-PCP 4 construct with holo-module 5 and left to stand for 2 h. The reaction contained 100 mM peptidyl-S-PCP 4, 10 mM holo-module 5 2.5 mM ATP and 1 mM L-pHPG in assay buffer. Proteins were removed by centrifugation through a 3k MWCO Amicon Ultra centrifugal filter. The filtrate was directly analysed by HPLC and products of interest were collected over multiple injections and concentrated by lyophilization. The concentrated samples were re-suspended in 70 ml of 95:5 water:ACN 1 0.1% formic acid and directly analysed by LC-MS.
Incubation of tetrapeptidyl-S-pantetheine 3 with holo-module 5. Reactions in which pantetheinyl substrate 3 was substituted for the holo-PCP 4 construct contained 1 mM 3, 10 mM holo-module 5 construct, 1 mM L-pHPG and 2.5 mM ATP and were left to stand for 2 h at room temperature in assay buffer. Reactions were quenched and analysed as described above. LETTER RESEARCH
